Parkinson Disease

Can Deep Brain Stimulation Improve Social, Occupational Functioning in Patients With Parkinson Disease?

August 11, 2020


Among patients with Parkinson disease aged 60 years and younger with early motor complications, deep brain stimulation was found to provide significant improvements in social, occupational, and psychosocial function.

What Obstacles Are Impeding Early Diagnosis of Parkinson Disease?

August 06, 2020


Improving on the ability to confirm diagnosis of Parkinson disease (PD) earlier and determining who is at risk for PD were referenced as key factors in further slowing progression of the disease, according to review findings.

What Emerging Drug Therapies Are in the Clinical Trial Pipeline for Parkinson Disease?

August 03, 2020


Overall, there are 145 registered and ongoing clinical trials for therapies targeting Parkinson disease, of which 28 are currently in phase 3, according to review findings.

Review Discusses Physical Impact of Nonmotor Symptoms in Parkinson Disease

July 30, 2020


Researchers discuss the implications of nonmotor symptoms in patients with Parkinson disease, which can contribute to major sleep, ocular, olfactory, throat, cardiovascular, gastrointestinal, genitourinary, or musculoskeletal disorders.

Concussion Associated With Greater Risk of Parkinson Disease, Dementia

July 28, 2020


Individuals who had experienced a concussion were found to be at a greater risk of Parkinson disease, mood and anxiety disorders (MADs), dementia, and hyperactivity disorder, with concussed women indicated as a notable at-risk population for MADs, according to study findings published today.

What Are the Implications of OFF Periods, Economic Burden in Parkinson Disease?

July 24, 2020


A recent webinar discussed what causes symptom recurrence in patients with Parkinson disease and what implications this has for health outcomes and health care cost.

MJFF COVID-19 Survey Highlights Adverse Implications for Patients With Parkinson Disease

July 23, 2020


Findings from the Michael J. Fox Foundation’s (MJFF) coronavirus disease 2019 (COVID-19) survey, based on patient-reported information from Fox Insight, highlight the known adverse effects of general infections on worsening of motor and nonmotor symptoms in patients with Parkinson disease (PD). However, there still remains insufficient data on the specified risk of COVID-19 in the PD community, noted Vanessa Arnedo, vice president of Research Cohorts for MJFF, and Ethan Brown, MD, neurologist and principal investigator of the MJFF COVID-19 survey.

Vision Issues in Patients With Parkinson Disease Linked With Behavioral, Cognitive Impairment

July 17, 2020


Patients with Parkinson disease who experience visual impairment were found to be more prone to behavioral issues such as depression and anxiety, as well as dementia and death, according to study findings.

What Can Improve On-Time Administration of Parkinson Disease Medications?

July 14, 2020


A quality improvement project led by a multidisciplinary team was found to significantly improve on-time administration of levodopa and other medications for patients with Parkinson disease, according to study findings.

Study Suggests Deep Brain Stimulation Does Not Increase Risk of Dementia in Patients With Parkinson Disease

July 10, 2020


In patients with Parkinson disease (PD) who underwent deep brain stimulation, dementia prevalence and incidence were not found to be higher than those in the general PD population, according to study findings.